Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads Digital Contract Notes Online Trading Demo News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Titan Biotech Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524717 border-img ISIN Demat INE150C01011 border-img Book Value 140.46 border-img NSE Symbol N.A border-img Div & Yield % 0.34 border-img Market Cap (₹ Cr.) 441.49 border-img P/E 18.81 border-img EPS 28.4 border-img Face Value 10
Date Headline
12-02-2024 Titan Biotech standalone net profit rises 173.33% in the December 2023 quarter
12-02-2024 Titan Biotech consolidated net profit rises 119.94% in the December 2023 quarter
01-02-2024 Titan Biotech to discuss results
28-12-2023 Titan Biotech Ltd - Closure of Trading Window
23-12-2023 Titan Biotech Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
23-12-2023 Titan Biotech Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
19-12-2023 Titan Biotech Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
16-11-2023 Titan Biotech Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
09-11-2023 Titan Biotech consolidated net profit declines 28.59% in the September 2023 quarter
28-10-2023 Titan Biotech to conduct board meeting
x
capstocks-logo
 
Date & Time -()
 

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |    Online Grievance Redressal

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 DP: IN-DP-CDSL-203-2003 PMS: INP000001066

Research Entity SEBI Reg No: INH200003109,

Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh